Catherine M Bollard Selected Research

Proteasome Inhibitors

1/2022

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine M Bollard Research Topics

Disease

78	Neoplasms (Cancer) 01/2022 - 03/2002
29	Lymphoma (Lymphomas) 01/2022 - 09/2005
27	Infections 10/2022 - 03/2006
27	Virus Diseases (Viral Diseases) 10/2022 - 10/2002
22	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 12/2006
18	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 05/2002
14	Hematologic Neoplasms (Hematological Malignancy) 09/2022 - 12/2014
11	Leukemia 01/2022 - 09/2010
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 06/2008
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 11/2008
6	Inflammation (Inflammations) 01/2021 - 07/2009
6	Melanoma (Melanoma, Malignant) 01/2021 - 11/2010
5	COVID-19 09/2022 - 01/2020
5	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 05/2011
5	Primary Immunodeficiency Diseases 01/2020 - 01/2017
5	Epstein-Barr Virus Infections 01/2017 - 09/2008
4	Cytokine Release Syndrome 09/2022 - 05/2018
4	Testicular Neoplasms (Testicular Cancer) 12/2021 - 10/2011
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2018 - 01/2008
3	Nasopharyngeal Carcinoma 05/2014 - 01/2003
2	Disease Progression 01/2022 - 01/2021
2	Hematologic Diseases (Blood Diseases) 01/2022 - 01/2018
2	Synovial Sarcoma (Synovioma) 12/2021 - 12/2011
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 09/2010
2	Brain Neoplasms (Brain Tumor) 11/2021 - 01/2019
2	Adenoviridae Infections (Adenovirus Infections) 01/2021 - 03/2006
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 09/2017
2	Paramyxoviridae Infections (Parainfluenza) 01/2020 - 12/2016
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020 - 01/2018
2	Neuroblastoma 01/2019 - 01/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Viremia 12/2020

Drug/Important Bio-Agent (IBA)

42	AntigensIBA 01/2022 - 01/2003
15	Chimeric Antigen ReceptorsIBA 09/2022 - 05/2011
13	Membrane Proteins (Integral Membrane Proteins)IBA 12/2020 - 12/2004
10	Antiviral Agents (Antivirals)IBA 10/2022 - 04/2010
10	CytokinesIBA 01/2021 - 05/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
9	EpitopesIBA 12/2021 - 09/2005
8	Viral AntigensIBA 09/2017 - 03/2002
7	Neoplasm Antigens (Tumor Antigens)IBA 10/2018 - 02/2004
5	SurvivinIBA 01/2022 - 10/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 05/2002
5	Peptides (Polypeptides)IBA 11/2021 - 04/2009
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 04/2009
4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 06/2011
4	tisagenlecleucelIBA 09/2022 - 01/2019
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 12/2017
4	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2018 - 05/2006
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	Rituximab (Mabthera)FDA Link 11/2021 - 12/2017
3	VaccinesIBA 01/2020 - 01/2008
3	Pharmaceutical PreparationsIBA 12/2019 - 01/2019
3	Interleukin-2 (IL2)IBA 07/2014 - 02/2004
2	InterferonsIBA 12/2021 - 10/2011
2	Prednisone (Sone)FDA LinkGeneric 11/2021 - 12/2017
2	Vincristine (Oncovin)FDA LinkGeneric 11/2021 - 12/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 12/2017
2	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 12/2017
2	RNA (Ribonucleic Acid)IBA 11/2021 - 06/2011
2	SteroidsIBA 01/2021 - 01/2019
2	AntibodiesIBA 01/2021 - 09/2019
2	ChemokinesIBA 12/2020 - 10/2011
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019 - 10/2015
2	Monoclonal AntibodiesIBA 09/2017 - 11/2009
2	Interleukin-13IBA 10/2011 - 02/2004
2	Interleukin-12 (IL 12)IBA 10/2011 - 02/2004
2	Chemokine CCL17IBA 10/2011 - 02/2004
2	Viral ProteinsIBA 10/2007 - 09/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	blinatumomabIBA 09/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	NivolumabIBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	LigandsIBA 01/2021
1	Brentuximab VedotinIBA 01/2021
1	CalcineurinIBA 01/2021
1	ProteomeIBA 12/2020
1	nelarabine (506U78)FDA Link 10/2020
1	Methotrexate (Mexate)FDA LinkGeneric 10/2020
1	pegaspargase (Oncaspar)FDA Link 10/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020
1	4- ((1- butyl- 3- phenylureido)methyl)- N- hydroxybenzamideIBA 01/2020

Therapy/Procedure

74	Therapeutics 10/2022 - 10/2002
48	Immunotherapy 01/2022 - 10/2002
29	Hematopoietic Stem Cell Transplantation 10/2022 - 03/2006
24	Transplantation 01/2022 - 11/2008
17	Drug Therapy (Chemotherapy) 01/2022 - 05/2010
17	Stem Cell Transplantation 01/2021 - 03/2004
7	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2020 - 05/2006
6	Cell Transplantation 01/2022 - 12/2015
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 06/2015
4	Art Therapy 12/2020 - 01/2016
2	Homologous Transplantation 10/2022 - 08/2013
2	Salvage Therapy 01/2022 - 01/2021
2	Photothermal Therapy 01/2020 - 01/2017
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 07/2016 - 09/2010
1	Radiotherapy 11/2021